Charles Schiffer, MD, Oncology, Detroit, MI, DMC - Detroit Receiving Hospital

CharlesAlanSchifferMD

Oncology Detroit, MI

Hematologic Oncology

Professor, Internal Medicine, Wayne State University School of Medicine

Dr. Schiffer is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Schiffer's full profile

Already have an account?

Education & Training

  • University of Maryland
    University of MarylandResidency, Internal Medicine, 1974 - 1975
  • NYU School of Medicine
    NYU School of MedicineResidency, Internal Medicine, 1968 - 1972
  • NYU School of Medicine
    NYU School of MedicineClass of 1968

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 1997 - 2022
  • MD State Medical License
    MD State Medical License 1975 - 1997
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Fellow (FASCO) American Society of Clinical Oncologists, 2010
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AML  
    Charles Schiffer, MD, New England Journal of Medicine

Abstracts/Posters

  • Combined Treatment with Lenalidomide and Epoetin Alfa Leads to Durable Responses in Patients with Epo-Refractory, Lower Risk Non-Deletion 5q [Del(5q)] MDS: Final Resul...
    Charles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Patient-Reported Outcome Results from the U.S. Life after Stopping TKIs (LAST) Study in Patients with Chronic Myeloid Leukemia
    Charles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • High Dependence on Medicare and Foundation Grant Assistance Among Patients with Hematologic Malignancies Receiving Novel Oral Therapeutics
    Charles A. Schiffer, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Other

Authored Content

  • Promoting Apoptosis with Venetoclax — A Benefit for Older Patients with AMLAugust 2020

Press Mentions

  • Schiffer Spotlights Potential for TKI Discontinuation in Select Patients with CML
    Schiffer Spotlights Potential for TKI Discontinuation in Select Patients with CMLOctober 31, 2020 14:15
  • Combo Protocol Promising for Older AML Patients
    Combo Protocol Promising for Older AML PatientsAugust 14, 2020 10:51

Grant Support

  • Transfusion Trial To Prevent Platelet AlloimmunizationNational Heart, Lung, And Blood Institute1994–1995
  • Mechanisms Of Drug Resistance In Acute Myeloid LeukemiaNational Cancer Institute1990–1994
  • Transfusion Trial To Prevent Platelet AllolimmunizationNational Heart, Lung, And Blood Institute1989–1993
  • Mechanisms Of Platelet RefractorinessNational Heart, Lung, And Blood Institute1986–1988

Professional Memberships

Hospital Affiliations